Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:1863-1867
doi: 10.1161/hc4201.097189
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greenland, P.
Right arrow Articles by Grundy, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greenland, P.
Right arrow Articles by Grundy, S. M.
Related Collections
Right arrow Primary prevention
Right arrow Secondary prevention
Right arrow Exercise testing
Right arrow CT and MRI
Right arrow Other diagnostic testing

(Circulation. 2001;104:1863.)
© 2001 American Heart Association, Inc.


Current Perspective

Improving Coronary Heart Disease Risk Assessment in Asymptomatic People

Role of Traditional Risk Factors and Noninvasive Cardiovascular Tests

Philip Greenland, MD; Sidney C. Smith Jr, MD; Scott M. Grundy, MD PhD

From the Departments of Preventive Medicine and Medicine, Northwestern University Medical School, Chicago, Ill (P.G.); the Division of Cardiology, Center for Cardiovascular Science and Medicine, University of North Carolina at Chapel Hill (S.C.S.); and the Departments of Clinical Nutrition and Internal Medicine, University of Texas Southwestern Medical Center, Dallas (S.M.G.).

Correspondence to Philip Greenland, MD, Department of Preventive Medicine, Northwestern University Medical School, 680 N Lake Shore Dr, Suite 1102, Chicago, IL 60611. E-mail p-greenland@northwestern.edu


Key Words: coronary disease • prevention • prognosis • risk factors


*    Introduction
 
At least 25% of coronary patients have sudden death or nonfatal myocardial infarction without prior symptoms.1 Therefore, the search for coronary patients with subclinical disease who could potentially benefit from intensive primary prevention efforts is critically important. The American Heart Association’s (AHA) Prevention V Conference, "Beyond Secondary Prevention: Identifying the High Risk Patient for Primary Prevention," addressed ways to identify more patients who are asymptomatic and clinically free of coronary heart disease (CHD) but at sufficiently high risk for a future coronary event to justify more intensive risk reduction efforts.2 In this report, we amplify on key findings and recommendations of the AHA Prevention V conference, highlight new research since the conference, and propose an approach to the use of office-based testing and additional noninvasive procedures in selected patients to better define their coronary event risk. The recommendations are concordant with the recently released approach to risk assessment and management from the third report of the Adult Treatment Panel of the National Cholesterol Education Program (ATP-III).3

Enthusiasm for primary prevention and risk assessment in asymptomatic people has been spurred by recent advances in prevention research. Lipid-lowering trials demonstrated that primary prevention of coronary events is feasible, evidenced by the West of Scotland Coronary Primary Prevention Study (WOSCOPS) trial4 of hypercholesterolemic men and by the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) trial5 in average or typical risk men and women with only moderate lipid abnormalities. Aspirin6 or ACE inhibitors7 can also reduce risk in selected asymptomatic, high-risk people. Emerging coronary . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
NEJMHome page
R. O. Bonow
Should Coronary Calcium Screening Be Used in Cardiovascular Prevention Strategies?
N. Engl. J. Med., September 3, 2009; 361(10): 990 - 997.
[Full Text] [PDF]


Home page
Eur Heart JHome page
W. Sturm, A. Tschoner, J. Engl, S. Kaser, M. Laimer, C. Ciardi, A. Klaus, H. Weiss, A. Sandhofer, J. R. Patsch, et al.
Effect of bariatric surgery on both functional and structural measures of premature atherosclerosis
Eur. Heart J., August 2, 2009; 30(16): 2038 - 2043.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
R. Kones
The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease
Therapeutic Advances in Cardiovascular Disease, August 1, 2009; 3(4): 309 - 315.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
N. R. Cook and P. M Ridker
Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures
Ann Intern Med, June 2, 2009; 150(11): 795 - 802.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc GenetHome page
A. Brautbar, C. M. Ballantyne, K. Lawson, V. Nambi, L. Chambless, A. R. Folsom, J. T. Willerson, and E. Boerwinkle
Impact of Adding a Single Allele in the 9p21 Locus to Traditional Risk Factors on Reclassification of Coronary Heart Disease Risk and Implications for Lipid-Modifying Therapy in the Atherosclerosis Risk in Communities Study
Circ Cardiovasc Genet, June 1, 2009; 2(3): 279 - 285.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
W. Koenig
Is hsCRP Back on Board? Implications from the JUPITER Trial
Clin. Chem., February 1, 2009; 55(2): 216 - 218.
[Full Text] [PDF]


Home page
BMJHome page
I. A Scott
Evaluating cardiovascular risk assessment for asymptomatic people
BMJ, January 5, 2009; 338(jan05_1): a2844 - a2844.
[Full Text]


Home page
J. Epidemiol. Community HealthHome page
C Power, K Atherton, and O Manor
Co-occurrence of risk factors for cardiovascular disease by social class: 1958 British birth cohort
J Epidemiol Community Health, December 1, 2008; 62(12): 1030 - 1035.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
K. McGeechan, P. Macaskill, L. Irwig, G. Liew, and T. Y. Wong
Assessing New Biomarkers and Predictive Models for Use in Clinical Practice: A Clinician's Guide
Arch Intern Med, November 24, 2008; 168(21): 2304 - 2310.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc Qual OutcomesHome page
P. W.F. Wilson, M. Pencina, P. Jacques, J. Selhub, R. D'Agostino Sr, and C. J. O'Donnell
C-Reactive Protein and Reclassification of Cardiovascular Risk in the Framingham Heart Study
Circ Cardiovasc Qual Outcomes, November 1, 2008; 1(2): 92 - 97.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. N. Barnes and H. Tanaka
Commentary on Viewpoint: Exercise and cardiovascular risk reduction: Time to update the rationale for exercise?
J Appl Physiol, August 1, 2008; 105(2): 777 - 777.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Dhindsa, S. M. Sommerlad, A. E. DeVan, J. N. Barnes, J. Sugawara, O. Ley, and H. Tanaka
Interrelationships among noninvasive measures of postischemic macro- and microvascular reactivity
J Appl Physiol, August 1, 2008; 105(2): 427 - 432.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
Ankle Brachial Index Collaboration
Ankle Brachial Index Combined With Framingham Risk Score to Predict Cardiovascular Events and Mortality: A Meta-analysis
JAMA, July 9, 2008; 300(2): 197 - 208.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
K. C. Hoang, H. Ghandehari, V. A. Lopez, M. G. Barboza, and N. D. Wong
Global Coronary Heart Disease Risk Assessment of Individuals With the Metabolic Syndrome in the U.S.
Diabetes Care, July 1, 2008; 31(7): 1405 - 1409.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
A. R. Folsom, R. A. Kronmal, R. C. Detrano, D. H. O'Leary, D. E. Bild, D. A. Bluemke, M. J. Budoff, K. Liu, S. Shea, M. Szklo, et al.
Coronary Artery Calcification Compared With Carotid Intima-Media Thickness in the Prediction of Cardiovascular Disease Incidence: The Multi-Ethnic Study of Atherosclerosis (MESA)
Arch Intern Med, June 23, 2008; 168(12): 1333 - 1339.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Juonala, M. Kahonen, T. Laitinen, N. Hutri-Kahonen, E. Jokinen, L. Taittonen, M. Pietikainen, H. Helenius, J. S.A. Viikari, and O. T. Raitakari
Effect of age and sex on carotid intima-media thickness, elasticity and brachial endothelial function in healthy adults: The Cardiovascular Risk in Young Finns Study
Eur. Heart J., May 1, 2008; 29(9): 1198 - 1206.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Davidson, P. M. Meyer, S. Haffner, S. Feinstein, R. D'Agostino Sr, G. T. Kondos, A. Perez, Z. Chen, and T. Mazzone
Increased High-Density Lipoprotein Cholesterol Predicts the Pioglitazone-Mediated Reduction of Carotid Intima-Media Thickness Progression in Patients With Type 2 Diabetes Mellitus
Circulation, April 22, 2008; 117(16): 2123 - 2130.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. Detrano, A. D. Guerci, J. J. Carr, D. E. Bild, G. Burke, A. R. Folsom, K. Liu, S. Shea, M. Szklo, D. A. Bluemke, et al.
Coronary Calcium as a Predictor of Coronary Events in Four Racial or Ethnic Groups
N. Engl. J. Med., March 27, 2008; 358(13): 1336 - 1345.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Rossi, A. Nuzzo, G. Origliani, and M. G. Modena
Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women.
J. Am. Coll. Cardiol., March 11, 2008; 51(10): 997 - 1002.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. S. Blumenthal, C. N. Bairey Merz, V. Bittner, and T. J. Gluckman
Task Force 10: Training in Preventive Cardiovascular Medicine
J. Am. Coll. Cardiol., January 22, 2008; 51(3): 393 - 398.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
N. R. Cook
Statistical Evaluation of Prognostic versus Diagnostic Models: Beyond the ROC Curve
Clin. Chem., January 1, 2008; 54(1): 17 - 23.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
S. R. Preis and C. J. O'Donnell
Coronary Heart Disease Risk Assessment by Traditional Risk Factors and Newer Subclinical Disease Imaging: Is a "One-Size-Fits-All" Approach the Best Option?
Arch Intern Med, December 10, 2007; 167(22): 2399 - 2401.
[Full Text] [PDF]


Home page
JNMHome page
T. Schepis, O. Gaemperli, P. Koepfli, M. Namdar, I. Valenta, H. Scheffel, S. Leschka, L. Husmann, F. R. Eberli, T. F. Luscher, et al.
Added Value of Coronary Artery Calcium Score as an Adjunct to Gated SPECT for the Evaluation of Coronary Artery Disease in an Intermediate-Risk Population
J. Nucl. Med., September 1, 2007; 48(9): 1424 - 1430.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
I. Kardys, R. Vliegenthart, M. Oudkerk, A. Hofman, and J. C. M. Witteman
The Female Advantage in Cardiovascular Disease: Do Vascular Beds Contribute Equally?
Am. J. Epidemiol., August 15, 2007; 166(4): 403 - 412.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Arena, J. Myers, M. A. Williams, M. Gulati, P. Kligfield, G. J. Balady, E. Collins, and G. Fletcher
Assessment of Functional Capacity in Clinical and Research Settings: A Scientific Statement From the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing
Circulation, July 17, 2007; 116(3): 329 - 343.
[Full Text] [PDF]


Home page
CirculationHome page
W. Koenig
Cardiovascular Biomarkers: Added Value With an Integrated Approach?
Circulation, July 3, 2007; 116(1): 3 - 5.
[Full Text] [PDF]


Home page
Clin. DiabetesHome page
G. D. Harris
A 52-Year-Old Woman With Hypertension and Diabetes Who Presents With Chest Pain
Clin. Diabetes, July 1, 2007; 25(3): 115 - 118.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
X. Sui, M. J. LaMonte, and S. N. Blair
Cardiorespiratory Fitness as a Predictor of Nonfatal Cardiovascular Events in Asymptomatic Women and Men
Am. J. Epidemiol., June 15, 2007; 165(12): 1413 - 1423.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. M. Blanco-Colio, J. L. Martin-Ventura, B. Munoz-Garcia, J. Orbe, J. A. Paramo, J.-B. Michel, A. Ortiz, O. Meilhac, and J. Egido
Identification of Soluble Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (sTWEAK) as a Possible Biomarker of Subclinical Atherosclerosis
Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 916 - 922.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. S. Lauer
Primary Prevention of Atherosclerotic Cardiovascular Disease: The High Public Burden of Low Individual Risk
JAMA, March 28, 2007; 297(12): 1376 - 1378.
[Full Text] [PDF]


Home page
CirculationHome page
J. G. Keevil, M. W. Cullen, R. Gangnon, P. E. McBride, and J. H. Stein
Implications of Cardiac Risk and Low-Density Lipoprotein Cholesterol Distributions in the United States for the Diagnosis and Treatment of Dyslipidemia: Data From National Health and Nutrition Examination Survey 1999 to 2002
Circulation, March 20, 2007; 115(11): 1363 - 1370.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
P. Thavendiranathan, A. Bagai, M. A. Brookhart, and N. K. Choudhry
Primary Prevention of Cardiovascular Diseases With Statin Therapy: A Meta-analysis of Randomized Controlled Trials
Arch Intern Med, November 27, 2006; 166(21): 2307 - 2313.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. J. Budoff, S. Achenbach, R. S. Blumenthal, J. J. Carr, J. G. Goldin, P. Greenland, A. D. Guerci, J. A.C. Lima, D. J. Rader, G. D. Rubin, et al.
Assessment of Coronary Artery Disease by Cardiac Computed Tomography: A Scientific Statement From the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology
Circulation, October 17, 2006; 114(16): 1761 - 1791.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. J. Budoff
Prevalence of Soft Plaque Detection With Computed Tomography
J. Am. Coll. Cardiol., July 18, 2006; 48(2): 319 - 321.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
N. R. Cook, J. E. Buring, and P. M Ridker
The Effect of Including C-Reactive Protein in Cardiovascular Risk Prediction Models for Women
Ann Intern Med, July 4, 2006; 145(1): 21 - 29.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
P. Raggi
Noninvasive imaging of atherosclerosis among asymptomatic individuals.
Arch Intern Med, May 22, 2006; 166(10): 1068 - 1071.
[Full Text] [PDF]


Home page
CirculationHome page
R. S. Vasan
Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations
Circulation, May 16, 2006; 113(19): 2335 - 2362.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. D. Brook, R. L. Bard, S. Patel, M. Rubenfire, N. S. Clarke, E. A. Kazerooni, T. W. Wakefield, P. K. Henke, and K. A. Eagle
A Negative Carotid Plaque Area Test Is Superior to Other Noninvasive Atherosclerosis Studies for Reducing the Likelihood of Having Underlying Significant Coronary Artery Disease
Arterioscler Thromb Vasc Biol, March 1, 2006; 26(3): 656 - 662.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. Jerico, H. Knobel, N. Calvo, M. L. Sorli, A. Guelar, J. L. Gimeno-Bayon, P. Saballs, J. L. Lopez-Colomes, and J. Pedro-Botet
Subclinical Carotid Atherosclerosis in HIV-Infected Patients: Role of Combination Antiretroviral Therapy
Stroke, March 1, 2006; 37(3): 812 - 817.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
E. Escolar, G. Weigold, A. Fuisz, and N. J. Weissman
New imaging techniques for diagnosing coronary artery disease.
Can. Med. Assoc. J., February 14, 2006; 174(4): 487 - 495.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
N.F. Fanning, T.D. Walters, A.J. Fox, and S.P. Symons
Association between Calcification of the Cervical Carotid Artery Bifurcation and White Matter Ischemia.
AJNR Am. J. Neuroradiol., February 1, 2006; 27(2): 378 - 383.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
A Cordero and E Alegria
Sex differences and cardiovascular risk
Heart, February 1, 2006; 92(2): 145 - 146.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
I. J. Kullo, G. Li, L. F. Bielak, K. R. Bailey, P. F. Sheedy II, P. A. Peyser, S. T. Turner, and S. L. R. Kardia
Association of Plasma Homocysteine With Coronary Artery Calcification in Different Categories of Coronary Heart Disease Risk
Mayo Clin. Proc., February 1, 2006; 81(2): 177 - 182.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
P. Greenland and P. G. O'Malley
When Is a New Prediction Marker Useful?: A Consideration of Lipoprotein-Associated Phospholipase A2 and C-Reactive Protein for Stroke Risk
Arch Intern Med, November 28, 2005; 165(21): 2454 - 2456.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
P. W. F. Wilson, B.-H. Nam, M. Pencina, R. B. D'Agostino Sr, E. J. Benjamin, and C. J. O'Donnell
C-Reactive Protein and Risk of Cardiovascular Disease in Men and Women From the Framingham Heart Study
Arch Intern Med, November 28, 2005; 165(21): 2473 - 2478.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Mora, R. F. Redberg, A. R. Sharrett, and R. S. Blumenthal
Enhanced Risk Assessment in Asymptomatic Individuals With Exercise Testing and Framingham Risk Scores
Circulation, September 13, 2005; 112(11): 1566 - 1572.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. J. Taylor, J. Bindeman, I. Feuerstein, F. Cao, M. Brazaitis, and P. G. O'Malley
Coronary Calcium Independently Predicts Incident Premature Coronary Heart Disease Over Measured Cardiovascular Risk Factors: Mean Three-Year Outcomes in the Prospective Army Coronary Calcium (PACC) Project
J. Am. Coll. Cardiol., September 6, 2005; 46(5): 807 - 814.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Lauer, E. S. Froelicher, M. Williams, and P. Kligfield
Exercise Testing in Asymptomatic Adults: A Statement for Professionals From the American Heart Association Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention
Circulation, August 2, 2005; 112(5): 771 - 776.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Cushman, A. M. Arnold, B. M. Psaty, T. A. Manolio, L. H. Kuller, G. L. Burke, J. F. Polak, and R. P. Tracy
C-Reactive Protein and the 10-Year Incidence of Coronary Heart Disease in Older Men and Women: The Cardiovascular Health Study
Circulation, July 5, 2005; 112(1): 25 - 31.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. J. Campbell, M. Woodward, J. P. Chalmers, S. A. Colman, A. J. Jenkins, B. E. Kemp, B. C. Neal, A. Patel, and S. W. MacMahon
Prediction of Myocardial Infarction by N-Terminal-Pro-B-Type Natriuretic Peptide, C-Reactive Protein, and Renin in Subjects With Cerebrovascular Disease
Circulation, July 5, 2005; 112(1): 110 - 116.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. K. Aktas and M. S. Lauer
Global Risk Score and Exercise Testing--Reply
JAMA, January 12, 2005; 293(2): 160 - 160.
[Full Text] [PDF]


Home page
JAMAHome page
S. D. Persell
Global Risk Score and Exercise Testing
JAMA, January 12, 2005; 293(2): 159 - 159.
[Full Text] [PDF]


Home page
Eur Heart JHome page
O. Beloqui, J. A. Paramo, J. Orbe, A. Benito, I. Colina, A. Monasterio, and J. Diez
Monocyte cyclooxygenase-2 overactivity: a new marker of subclinical atherosclerosis in asymptomatic subjects with cardiovascular risk factors?
Eur. Heart J., January 2, 2005; 26(2): 153 - 158.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. C. Smith Jr, J. L. Anderson, R. O. Cannon III, Y. Y. Fadl, W. Koenig, P. Libby, S. E. Lipshultz, G. A. Mensah, P. M Ridker, and R. Rosenson
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Report From the Clinical Practice Discussion Group
Circulation, December 21, 2004; 110(25): e550 - e553.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
T. C. Register, K. P. Burdon, L. Lenchik, D. W. Bowden, G. A. Hawkins, B. J. Nicklas, K. Lohman, F.-C. Hsu, C. D. Langefeld, and J. J. Carr
Variability of Serum Soluble Intercellular Adhesion Molecule-1 Measurements Attributable to a Common Polymorphism
Clin. Chem., November 1, 2004; 50(11): 2185 - 2187.
[Full Text] [PDF]


Home page
CirculationHome page
W. Koenig, N. Khuseyinova, H. Lowel, G. Trischler, and C. Meisinger
Lipoprotein-Associated Phospholipase A2 Adds to Risk Prediction of Incident Coronary Events by C-Reactive Protein in Apparently Healthy Middle-Aged Men From the General Population: Results From the 14-Year Follow-Up of a Large Cohort From Southern Germany
Circulation, October 5, 2004; 110(14): 1903 - 1908.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. K. Aktas, V. Ozduran, C. E. Pothier, R. Lang, and M. S. Lauer
Global Risk Scores and Exercise Testing for Predicting All-Cause Mortality in a Preventive Medicine Program
JAMA, September 22, 2004; 292(12): 1462 - 1468.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. M. Herrington, W. V. Brown, L. Mosca, W. Davis, B. Eggleston, W. G. Hundley, and J. Raines
Relationship Between Arterial Stiffness and Subclinical Aortic Atherosclerosis
Circulation, July 27, 2004; 110(4): 432 - 437.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. M Ridker, P. W.F. Wilson, and S. M. Grundy
Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk?
Circulation, June 15, 2004; 109(23): 2818 - 2825.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Morshedi-Meibodi, J. C. Evans, D. Levy, M. G. Larson, and R. S. Vasan
Clinical Correlates and Prognostic Significance of Exercise-Induced Ventricular Premature Beats in the Community: The Framingham Heart Study
Circulation, May 25, 2004; 109(20): 2417 - 2422.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Koenig, H. Lowel, J. Baumert, and C. Meisinger
C-Reactive Protein Modulates Risk Prediction Based on the Framingham Score: Implications for Future Risk Assessment: Results From a Large Cohort Study in Southern Germany
Circulation, March 23, 2004; 109(11): 1349 - 1353.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. M. Ballantyne, R. C. Hoogeveen, H. Bang, J. Coresh, A. R. Folsom, G. Heiss, and A. R. Sharrett
Lipoprotein-Associated Phospholipase A2, High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study
Circulation, February 24, 2004; 109(7): 837 - 842.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
P. Greenland, L. LaBree, S. P. Azen, T. M. Doherty, and R. C. Detrano
Coronary Artery Calcium Score Combined With Framingham Score for Risk Prediction in Asymptomatic Individuals
JAMA, January 14, 2004; 291(2): 210 - 215.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Verma, M. R. Buchanan, and T. J. Anderson
Endothelial Function Testing as a Biomarker of Vascular Disease
Circulation, October 28, 2003; 108(17): 2054 - 2059.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
A. B. Newman, A. M. Arnold, B. L. Naydeck, L. P. Fried, G. L. Burke, P. Enright, J. Gottdiener, C. Hirsch, D. O'Leary, and R. Tracy
"Successful Aging": Effect of Subclinical Cardiovascular Disease
Arch Intern Med, October 27, 2003; 163(19): 2315 - 2322.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. B. Mark and M. S. Lauer
Exercise Capacity: The Prognostic Variable That Doesn't Get Enough Respect
Circulation, September 30, 2003; 108(13): 1534 - 1536.
[Full Text] [PDF]


Home page
JAMAHome page
S. Mora, R. F. Redberg, Y. Cui, M. K. Whiteman, J. A. Flaws, A. R. Sharrett, and R. S. Blumenthal
Ability of Exercise Testing to Predict Cardiovascular and All-Cause Death in Asymptomatic Women: A 20-Year Follow-up of the Lipid Research Clinics Prevalence Study
JAMA, September 24, 2003; 290(12): 1600 - 1607.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
L. J. Shaw, P. Raggi, E. Schisterman, D. S. Berman, and T. Q. Callister
Prognostic Value of Cardiac Risk Factors and Coronary Artery Calcium Screening for All-Cause Mortality
Radiology, September 1, 2003; 228(3): 826 - 833.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. J. Wang, B.-H. Nam, R. B. D'Agostino, P. A. Wolf, D. M. Lloyd-Jones, C. A. MacRae, P. W. Wilson, J. F. Polak, and C. J. O'Donnell
Carotid Intima-Media Thickness Is Associated With Premature Parental Coronary Heart Disease: The Framingham Heart Study
Circulation, August 5, 2003; 108(5): 572 - 576.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. Greenland and J. M. Gaziano
Selecting Asymptomatic Patients for Coronary Computed Tomography or Electrocardiographic Exercise Testing
N. Engl. J. Med., July 31, 2003; 349(5): 465 - 473.
[Full Text] [PDF]


Home page
Eur Heart JHome page
T. H Marwick, C. Case, L. Short, and J. D Thomas
Prediction of mortality in patients without angina: Use of an exercise score and exercise echocardiography
Eur. Heart J., July 1, 2003; 24(13): 1223 - 1230.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. C. Pasternak, J. Abrams, P. Greenland, L. A. Smaha, P. W. F. Wilson, and N. Houston-Miller
Task force #1--identification of coronary heart disease risk: is there a detection gap?
J. Am. Coll. Cardiol., June 4, 2003; 41(11): 1863 - 1874.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. W. F. Wilson, S. C. Smith Jr, R. S. Blumenthal, G. L. Burke, and N. D. Wong
Task force #4--how do we select patients for atherosclerosis imaging?
J. Am. Coll. Cardiol., June 4, 2003; 41(11): 1898 - 1906.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
D. B. Mark, L. J. Shaw, M. S. Lauer, P. G. O'Malley, and P. Heidenreich
Task force #5--is atherosclerosis imaging cost effective?
J. Am. Coll. Cardiol., June 4, 2003; 41(11): 1906 - 1917.
[Full Text] [PDF]


Home page
CirculationHome page
G. T. Kondos, J. A. Hoff, A. Sevrukov, M. L. Daviglus, D. B. Garside, S. S. Devries, E. V. Chomka, and K. Liu
Electron-Beam Tomography Coronary Artery Calcium and Cardiac Events: A 37-Month Follow-Up of 5635 Initially Asymptomatic Low- to Intermediate-Risk Adults
Circulation, May 27, 2003; 107(20): 2571 - 2576.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
P. G. O'Malley, I. M. Feuerstein, and A. J. Taylor
Impact of Electron Beam Tomography, With or Without Case Management, on Motivation, Behavioral Change, and Cardiovascular Risk Profile: A Randomized Controlled Trial
JAMA, May 7, 2003; 289(17): 2215 - 2223.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
P. Greenland
Improving Risk of Coronary Heart Disease: Can a Picture Make the Difference?
JAMA, May 7, 2003; 289(17): 2270 - 2272.
[Full Text] [PDF]


Home page
Diabetes CareHome page
M. J. Budoff
Point: Diabetic Patients and Coronary Calcium: Risk stratification, compliance, and plaque progression
Diabetes Care, February 1, 2003; 26(2): 541 - 542.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. B. Newman, B. L. Naydeck, K. Sutton-Tyrrell, D. Edmundowicz, D. O'Leary, R. Kronmal, G. L. Burke, and L. H. Kuller
Relationship Between Coronary Artery Calcification and Other Measures of Subclinical Cardiovascular Disease in Older Adults
Arterioscler Thromb Vasc Biol, October 1, 2002; 22(10): 1674 - 1679.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. K. Weinberg, D. Ackman, S. Glied, J. P. L. Nunes, J. W. Hurst, J. E. Ehrlich, J. A. Rumberger, A. G. Wasserman, M. Rosenthal, R. G. Frank, et al.
Direct-to-Consumer Marketing
N. Engl. J. Med., June 20, 2002; 346(25): 2010 - 2013.
[Full Text] [PDF]